SDRC Pilot and Feasibility Awards
2024 Pilot and Feasibility Awards
Based on our recent Pilot and Feasibility request for applications, we received 14 project proposals. With the support of MCHRI to complement the NIH P30 funding, the Stanford Diabetes Research Center (SDRC) proudly announces the following 7 awardees.
SDRC is committed to providing support for the most innovative and unique research proposals related to diabetes in all disciplines. Our goal is to support, enhance and foster new ideas that will improve how we understand, diagnose, treat and care for diabetes and its complications. The P&F program is a DRC hallmark designed to meet this goal.
Thank you to all applicants for their submissions, and congratulations again to this year's awardees.
Antonios Chronopoulos, PhD, Instructor, Department of Medicine, Stanford University - “Hyperglycemia-Induced Matrix Remodeling: A Key Modulator of CAF Heterogeneity in Liver Fibrosis and Hepatocellular Carcinogenesis”
Mindy Lee, MD, PhD, Instructor, Department of Pediatrics, Stanford University- “Fine-Tuning of Patient Facing Messaging Using LLMs to Increase Engagement with Remote Patient Monitoring”
Minal Moharir, MD, Clinical Assistant Professor, Department of Medicine, Stanford University; Co-PI: Latha Palaniappan, MD, MS, Professor, Department of Medicine, Stanford University- “Validation of NOURISH Project's Culturally Tailored Meals on Postprandial Glycemic Response Using Continuous Glucose Monitoring: A Quantitative and Qualitative Study”
Lisa Goldman Rosas, PhD MPH, Assistant Professor, Department of Medicine, Stanford University- “Barriers and Facilitators for Implementing Food is Medicine Among Women”
Debra L Safer, MD, Professor, Department of Psychiatry, Stanford University; Tracey McLaughlin, MD, Professor, Department of Medicine, Stanford University- “After Tirzepatide: What happens to body composition and metabolic health?”
Sui Wang, PhD, Assistant Professor, Department of Ophthalmology, Stanford University- “Dissecting diabetes-induced cell-type-specific responses in human retina”
Gerlinde Wernig, MD, Assistant Professor, Department of Pathology, Stanford University- “Investigating the Mechanisms and Therapeutic Potential of SLC4A4 in Diabetic Nephropathy”
